Daniel R. Chevallard
Overview
Daniel R. Chevallard received an average of $631K in total compensation, including $264K in salary, at Regulus Therapeutics from 2017 to 2019.
Source: SEC filings on April 29, 2020, July 1, 2019, and April 20, 2018.
Related executives
We found ten more executives who work or worked at Regulus Therapeutics.
Joseph Hagan
Regulus Therapeutics
Chief Executive Officer
Christopher Aker
Regulus Therapeutics
General Counsel
Cris Calsada
Regulus Therapeutics
Chief Financial Officer
Timothy Wright
Regulus Therapeutics
Chief Research & Development Officer
Paul Grint
Regulus Therapeutics
Chief Executive Officer
Mark Deeg
Regulus Therapeutics
Chief Medical Officer
Kleanthis Xanthopoulos
Regulus Therapeutics
Chief Executive Officer
Neil Gibson
Regulus Therapeutics